ASH 2014 | Progress in the development of treatments for leukemia

Robin Foà

At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Robin Foà (Sapienza University, Rome, Italy) discusses how understanding disease biology leads to targeted therapies in different types of leukemia, including acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL) and acute lymphoblastic leukemia (ALL).

Share this video  
Similar topics